Skip to content

Frontlight ResearchEarly access

Institution

Nemours Children's Health System

Jacksonville, United StatesWebsite

3running trials
1closed trial
2,308publications (OpenAlex)

Running trials

Recruiting
Responding With Evidence and Access for Childhood Headaches
NCT05889624· Children's Hospital Medical Center, Cincinnati· Source
Recruiting
Precise Infliximab Exposure and Pharmacodynamic Control
NCT05660746· Phase 2/3· Children's Hospital Medical Center, Cincinnati· Source
Active, not recruiting
A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)
NCT02130362· AbbVie· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Closed trials

Completed
Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)
NCT04026113· Phase 3· AbbVie· Source

Registry name variants (4)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

Nemours Children's Health System
Wilmington, Delaware 19810
1 trial
- NCT05889624Responding With Evidence and Access for Childhood Headaches
  Contact: Jessica Rayfield
Nemours Children's Health System /ID# 148498
Jacksonville, Florida 32207
1 trial
- NCT02130362A Non-Interventional Clinical Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients With Moderately to Severely Active Crohn's Disease (CD)
Nemours Children's Health System /ID# 233127
Jacksonville, Florida 32207
1 trial
- NCT04026113Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)
Nemours Children's Health System-Jacksonville
Jacksonville, Florida 32207
1 trial
- NCT05660746Precise Infliximab Exposure and Pharmacodynamic Control
  Contact: Jill Dorsey

Conditions

Diseases this institution publishes on or runs trials for.

Institution data: ROR 01mzw6m29 (CC0-1.0)Updated 14 Nov 2026

Report an error

Nemours Children's Health System: trials and research groups – Frontlight Research